Skip to Main Content Menu Search Site

OMNIVAX: Broadly Deployable Infection Vaccine Platform

Robust first-in-class immuno-material-based vaccine technology to create safe and effective therapeutic and prophylactic vaccines against viral and bacterial infections

Want to invest in this technology?

The OMNIVAX team has significantly de-risked this technology and is currently seeking venture capital investment to assist with its commercialization.

Close menu